Cardiovascular; Attack, Cardiovascular Complication, Cardiovascular Stroke, Death, Liver Transplant; Complications
Conditions
Brief summary
All patients with orthotopic liver transplantation who are evaluated and followed at each participating centers will be recorded in this study. Within this register a characterization of patients and therapy will be done. Prognostic factors of defined clinical relevant endpoints will be evaluated.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* All patients with ortothopic liver transplantation and at least 2 year follow-up at the referral center
Exclusion criteria
* Missing Informed Consent Form * Missing Contact Informations for Follow up
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Cardiovascular death | From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 120 months | death due to cardiac causes (myocardial infraction and/or stroke) |
| cardiovascular complication | From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 120 months | fatal and non fatal myocardial infraction and/or stroke |
Countries
Italy